會前研討會 - 10月21日 - 日本標準時間(GMT+09:00)
會前研討會 - 10月21日 - 日本標準時間(GMT+09:00)
報到
上午研討會:CDMO管理概要
Add-on this optional pre-conference workshop to your main conference registration package and gain a comprehensive overview of CDMO Management in an easy-to-follow classroom setting to help you prepare for the main conference program.
Understanding the Japanese CDMO Landscape
- Introduction to Japanese Business Culture
- Historical Overview and Current Trends in the CDMO Industry
- Interactive Discussion
- Participants share their current understanding and experiences with Japanese CDMOs.
- Group activity: Identify key cultural differences that could impact business relationships.
Strategic Partnering with Japanese CDMOs
- Key Players and Capabilities in the Japanese CDMO Market
- CDMO Selection Frameworks
- Case Study, groups and presentations: CDMO Selection
Negotiation and Collaboration
- Collaboration Models
- Case Study, groups and presentations: Negotiation and Collaboration
- Small Group Discussions: Aligning Expectations
Execution, Relationship Maintenance, and Conflict Resolution
- Executing a Seamless Tech Transfer
- Maintaining Relationships and Conflict Resolution
- Interactive Session: Win-Win Thinking in Practice
- Final Q&A and Wrap-Up
- Workshop registration begins at 7:30 am
研討會報到開始時間:上午7:30 - Morning Break: -10:30-10:50
休息時間:上午10:30~10:50
- Stefan Sandstrom - CEO, Biosector Ltd., Japan
午餐會:提供給持有全體會議+半日研討會(2場)通行証之與會者
下午研討會:細胞與基因製造概要
Add-on this optional pre-conference workshop to your main conference registration package and gain a comprehensive overview of Cell and Gene Therapy Manufacturing in an easy-to-follow classroom setting to help you prepare for the main conference program.
- Workshop registration begins at 12:30 pm
研討會報到開始時間:下午12:30 - Afternoon Break: 3:30-3:50pm
休息時間:下午3:30~3:50
How does Cell and Gene Therapy Manufacturing Differ from other Biological Products?
- The manufacturing diversity of cell and gene products, examples.
- Limitations when controlling adventitious agents
- Complex starting and raw materials
- Batch size, and stability
- Christopher Bravery - Consulting Regulatory Scientist, Consulting on Advanced Biologicals, UK
* 活動內容有可能不事先告知作更動及調整。